Oncology & Cancer

No benefit of induction chemo, high-dose boost in anal cancer

(HealthDay) -- Neither induction chemotherapy (ICT) nor high-dose radiation boost is associated with an improvement in five-year colostomy-free survival (CFS) in patients with locally advanced anal canal carcinoma (LAACC), ...

Oncology & Cancer

Researchers demonstrate efficacy of non-Hodgkin's lymphoma vaccine

An experimental vaccine developed by researchers at the University of Pennsylvania's schools of Medicine and Veterinary Medicine is the first veterinary cancer vaccine of its kind that shows an increase in survival time for ...

page 3 from 3